UPDATE: Barclays Starts Jazz Pharmaceuticals (JAZZ) at Overweight; Use Share Weakness as Opportunity

Go back to UPDATE: Barclays Starts Jazz Pharmaceuticals (JAZZ) at Overweight; Use Share Weakness as Opportunity
JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) Delayed: 252.16 --0 (-0%)
Previous Close $252.16    52 Week High $160.00 
Open $252.16    52 Week Low $95.80 
Day High $252.16    P/E 46.87 
Day Low $252.16    EPS $5.38 
Volume 514